Detalles de la búsqueda
1.
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Ann Oncol
; 34(2): 200-211, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36423745
2.
Cutaneous presentation of progressive disseminated histoplasmosis nine years after renal transplantation.
Transpl Infect Dis
; 15(2): E64-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23387927
3.
Diabetic foot infections. Bacteriologic analysis.
Arch Intern Med
; 146(10): 1935-40, 1986 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3767539
4.
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Am J Med
; 96(4): 335-41, 1994 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-8166152
5.
Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
J Med Chem
; 31(10): 2008-14, 1988 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3172137
6.
Anaerobic flora of the normal human conjunctival sac.
Arch Ophthalmol
; 96(8): 1448-50, 1978 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-678185
7.
Clinical, pathogenetic, and laboratory features of Capnocytophaga infections.
Am J Clin Pathol
; 86(4): 513-8, 1986 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3766465
8.
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 17(4): 307-11, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8112046
9.
Multicenter comparison of the high volume (10 ml) NR BACTEC PLUS system and the standard (5 ml) NR BACTEC system.
Diagn Microbiol Infect Dis
; 14(2): 111-8, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1873969
10.
Development and evaluation of diagnostic radiometric assays for serogroup 4 L. pneumophila urinary antigens.
Diagn Microbiol Infect Dis
; 6(2): 101-7, 1987 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-3816128
11.
Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
Diagn Microbiol Infect Dis
; 8(2): 87-94, 1987 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-3480787
12.
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 17(2): 143-50, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8243035
13.
Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Diagn Microbiol Infect Dis
; 14(4): 361-4, 1991.
Artículo
en Inglés
| MEDLINE | ID: mdl-1889187
14.
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria.
Diagn Microbiol Infect Dis
; 16(3): 191-203, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8477573
15.
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years.
Diagn Microbiol Infect Dis
; 21(3): 153-68, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7648836
16.
Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628).
Diagn Microbiol Infect Dis
; 21(3): 175-9, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7648838
17.
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.
Diagn Microbiol Infect Dis
; 12(6): 489-94, 1989.
Artículo
en Inglés
| MEDLINE | ID: mdl-2560421
18.
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
Diagn Microbiol Infect Dis
; 9(1): 47-50, 1988 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-3370931
19.
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
Diagn Microbiol Infect Dis
; 9(1): 59-63, 1988 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-3370932
20.
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Diagn Microbiol Infect Dis
; 15(6): 537-43, 1992 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1424507